Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Bordetella pertussis ptxA/PTXS1 Protein, N-His

Catalog #:   YXX03501 Specific References (24) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: E. coli
Accession: P04977
Protein length: Asp35-Phe269
Overview

Catalog No.

YXX03501

Expression system

E. coli

Species

Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251)

Protein length

Asp35-Phe269

Predicted molecular weight

27.16 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

P04977

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 0.02% NLS, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution. A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Pertussis toxin subunit 1, PTX S1, Islet-activating protein S1, IAP S1, NAD-dependent ADP-ribosyltransferase, 2.4.2.-, ptxA, BP3783

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Bordetella pertussis (strain Tohama I / ATCC BAA-589 / NCTC 13251) ptxA/PTXS1 protein
References

Vaccine antigen-based genotyping of Bordetella pertussis by direct Sanger sequencing of clinical samples in Peru from 2018 to 2019., PMID:40366145

Bioinformatic development of a recombinant trivalent synthetic protein construct using PTXa, Tox, and TetX toxins as a DTP vaccine candidate., PMID:40256581

Surfaceome analysis of Australian epidemic Bordetella pertussis reveals potential vaccine antigens., PMID:31703933

Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016-2017: Clinical Features, Genotype Variations of Antigenic Genes and Macrolides Resistance., PMID:30882726

Characterisation of the Bordetella pertussis secretome under different media., PMID:28242451

[Antigenic variability of Bordetella pertussis strains isolated in 1967-2010 in the Czech Republic--possible explanation for the rise in cases of pertussis?]., PMID:26448300

Single Amino Acid Polymorphisms of Pertussis Toxin Subunit S2 (PtxB) Affect Protein Function., PMID:26375454

Genetic Variation of Bordetella pertussis in Austria., PMID:26182210

Pertussis in infants less than 6 months of age and household contacts, Italy, April 2014., PMID:25874559

Genetic analysis of Bordetella pertussis isolates from the 2008-2010 pertussis epidemic in Japan., PMID:24124606

Role of (p)ppGpp in biofilm formation and expression of filamentous structures in Bordetella pertussis., PMID:23676431

Small mutations in Bordetella pertussis are associated with selective sweeps., PMID:23029513

Synergic effect of genotype changes in pertussis toxin and pertactin on adaptation to an acellular pertussis vaccine in the murine intranasal challenge model., PMID:20357056

Bordetella pertussis vaccine strains and circulating isolates in Serbia., PMID:19945417

Rapid and accurate typing of Bordetella pertussis targeting genes encoding acellular vaccine antigens using real time PCR and High Resolution Melt analysis., PMID:19341769

Antigenic divergence between Bordetella pertussis clinical isolates from Moscow, Russia, and vaccine strains., PMID:17202309

Multitarget PCR for diagnosis of pertussis and its clinical implications., PMID:17151210

Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs., PMID:15956409

Analysis of Bordetella pertussis populations in European countries with different vaccination policies., PMID:15956406

Sequence variation and conservation in virulence-related genes of Bordetella pertussis isolates from the UK., PMID:15096543

Genotypic variation in the Bordetella pertussis virulence factors pertactin and pertussis toxin in historical and recent clinical isolates in the United Kingdom., PMID:11500425

Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes., PMID:10192507

BvgAS is sufficient for activation of the Bordetella pertussis ptx locus in Escherichia coli., PMID:7592423

Analysis of Bordetella pertussis virulence gene regulation by use of transcriptional fusions in Escherichia coli., PMID:2553678

Datasheet
$ 313
Product specifications
100 μg 313 1 mg 1629

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Bordetella pertussis ptxA/PTXS1 Protein, N-His [YXX03501]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only